Brief: Inozyme Pharma Reports Third Quarter Results

Inozyme Pharma

10/11/2022 16:35

Nov 10 (Reuters) - Inozyme Pharma Inc  INZY.O :
    * INOZYME PHARMA REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATES
    * Q3 LOSS PER SHARE $0.38
    * INOZYME -EXPECTS CASH, CASH EQUIVALENTS,INVESTMENTS,
REMAINDER
OF FIRST TRANCHE OF DEBT FACILITY TO ENABLE FUND CASH FLOW
REQUIREMENTS INTO Q2 2024
    * Q3 EARNINGS PER SHARE VIEW $-0.43 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbSDBVy 
Further company coverage:  INZY.O 
 ((reuters.briefs@thomsonreuters.com;))